Clinical Trial Update: Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety of the TimoD Sustained-Release Implant in participants with glaucoma or ocular hypertension undergoing cataract sur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• TimoD Sustained-Release Implant

Snippet

Sponsor: EyeD Pharma | Conditions: Glaucoma, Ocular Hypertension | Phase 1 | Status: RECRUITING